During the past decade, Dermatovenerologicka ambulance conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 4 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 3 clinical trials were completed. i.e. 300% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Dermatovenerologicka ambulance" are "Dermatitis, Atopic" (2 trials), "Psoriasis" (2 trials), "Atopic Dermatitis" (1 trials) and "Psoriatic Arthritis" (1 trials). Many other conditions were trialed in "Dermatovenerologicka ambulance" in a lesser frequency.

Most popular intervention types in "Dermatovenerologicka ambulance" are "Drug" (5 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "Abrocitinib 100 mg" (1 trials), "Abrocitinib 200 mg" (1 trials), "Apremilast" (1 trials) and "Etanercept" (1 trials). Other intervention names were less common.

The vast majority of trials in "Dermatovenerologicka ambulance" are 5 trials for "All" genders.

Currently, there are NaN active trials in "Dermatovenerologicka ambulance". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Dermatovenerologicka ambulance, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Dermatovenerologicka ambulance, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".